FRS
0.026
160%
OCT
0.045
-42.3%
CRS
0.062
138.5%
NRZ
0.002
-33.3%
AVE
0.007
133.3%
CHM
0.006
-25%
LAT
0.074
111.4%
JAV
0.003
-25%
RLL
0.004
100%
HYD
0.019
-24%
SCN
0.027
80%
DUN
0.033
-23.3%
BP8
0.005
66.7%
TFL
0.01
-23.1%
EVR
0.005
66.7%
EXR
0.034
-22.7%
RGL
0.005
66.7%
GLL
0.007
-22.2%
SLM
0.105
66.7%
OZM
0.125
-21.9%
RR1
0.013
62.5%
TMG
0.036
-21.7%
RAS
0.025
56.3%
AGH
0.02
-20%
BGE
0.03
50%
CRR
0.004
-20%
CDT
0.003
50%
EM2
0.008
-20%
TMK
0.003
50%
CVL
1.06
-19.4%
BSX
0.051
45.7%
NWM
0.013
-18.8%
VIT
0.112
41.8%
AQD
0.04
-18.4%
CMO
0.024
41.2%
BUS
0.155
-18.4%
TOR
0.1
40.8%
LOT
0.195
-17%
EXT
0.018
38.5%
PUA
0.01
-16.7%

What’s Hot – COV, TYP, DES, BDX, TTM, BEZ & WCN

What’s Hot, Not & Doing
Brought to you by TSN Contributor & Wealth Advisor Nick Kelso

What’s Hot – COV, TYP, DES, BDX, TTM, BEZ & WCN
What’s Not – SER

What’s Hot
COV – Cleo Diagnostics Limited today closed up 41% to finish at 24c on $720k stock traded. The reason they were up today was because they announced a publication of a milestone article on its blood test for the accurate and early detection of ovarian cancer.

The article, entitled ‘Utility of a Multi-Marker Panel with Ultrasound for Enhanced Classification of Adnexal Mass’ was published in peer reviewed medical journal, Cancers.

The benchmarking study compared COV’s ovarian cancer blood test against the current standard clinical workflows that use CA125 and ultrasound to predict malignancy.

TYP – Tryptamine Therapeutics Limited (previously ExoPharm) today closed up 30% to finish at 2.6c on $1.2m stock traded. The reason they were up today was because they re-listed after raising $6.5m @ 2c through the boys and girls at Alto Capital who were kind enough to offer me a few.

Tryp is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs.

TYP has established clinical trial pathways for its two core programs being TRP-8803 (IV-infused psilocin formulation) and TRP-8802 (oral psilocybin).

DES – DeSoto Resources Limited today closed up 26% to finish at 9.6c on $2m stock traded. The reason they were up today was because they announced the acquisition of the Spectrum Project located in the NT.

Spectrum is a privately held block with historic high-grade rare earth elements of up to 50m @ 1.55% TREO from 245m including 6m @ 6.55% TREO from 248m.

Historic drilling intercepted high-grade REEs over 350m of a potential 4.5km strike along the Fenton Shear Zone (FSZ) corridor, with mineralisation open to the north and south.

BDX – Bcal Diagnostics Limited today closed up 25% to finish at 17.5c on $250k stock traded. There was no news out this morning but late last month they released its quarterly which highlighted that its internally managed SENSIBLE studies were completed.

BCAL is developing a blood-based test, BREASTEST for the detection of early-stage breast cancer.

These studies used prospectively collected Australian samples that were not previously analysed, to provide refinement of the lipid panel for BREASTEST.

TTM – Titan Minerals Limited today closed up 24% to finish at 3.1c on $760k stock traded. There was no news out today but earlier this month they announced assay results from its Dynasty Gold Project located in southern Ecuador.

New rock chip results confirming additional high-grade gold and silver well beyond existing resource with highlights of 8.71 g/t Au, 197 g/t Ag, 3.06% Cu, 20% Pb, 12.5% Zn.

In addition to significant rock chip results, recent soil geochemical results have unveiled multiple extensive open-ended arsenic anomalies within the Dynasty epithermal gold corridor.

BEZ – Besra Gold Limited today closed up 24% to finish at 11c on $500k stock traded. The reason they were up today was because yesterday after market they announced Quantum Metal Recovery successfully opened a US bank account in Australia with the CBA.

As a consequence, Quantum will now be able to meet the Malaysian regulatory requirements and commence sending US dollars from Malaysia directly to Quantum’s US CBA bank account.

Last year BEZ announced they signed a binding US$300m gold purchase agreement (GPA) with Quantum.

WCN – White Cliff Minerals Limited today closed up 13% to finish at 1.8c on $410k stock traded. There was no news out today but yesterday they announced preparations were underway for a maiden field campaign at its Nunavut Copper-Gold-Silver Project located in Northern Canada.

The recently acquired Nunavut Project represents a district scale opportunity at the pre-discovery stage underpinned by the presence of both high-grade, volcanic hosted copper-silver lodes and the prospect of large tonnage sedimentary hosted copper deposits.

Samples taken from Nunavut have returned assays of up to 30.7% Cu, 194g/t Ag while trench sampling results have returned 1.13m @ 16.75% Cu.

What’s Not
SER – Strategic Energy Resources Limited today closed down 17% to finish at 1.9c on $1.2m stock traded. There was no news out today but last week they announced a placement to raise $2m @ 1.1c through the boys and girls at Bell Potter.

The placement was cornerstoned by respected resources investment funds Datt Capital and Lowell Resources Fund, who are both yet to open accounts at the new joint.

Mr Tony Gu, a nominee of Datt Capital has been appointed as a non-executive director, he brings over a decade of experience in capital markets and investor relations.

Rats Rant – IMPORTANT INFORMATION
The idea of this report is to be informative and hopefully point out some stocks that you wouldn’t ordinarily have seen during the day, maybe even have a laugh too.This report IS NOT personal advice. Sanlam Private Wealth Pty Ltd DOES NOT PROVIDE personal advice, Sanlam Private Wealth provides General Financial Product Advice.All advice included in The Rat’s Rant is General Advice. Please refer to the General Advice Warning. The views expressed in this report are my views and may not necessarily reflect the same views as Sanlam Private Wealth.It is very important to refer to the ASX website for information on any companies / stock that are contained in this report and as always please consult your financial adviser before acting.

Important Notice
Rat Consulting Pty Ltd (ABN 81 148 181 588 ) Authorised Representative (No 001281456) of Sanlam Private Wealth Ltd (ABN 18 136 960 775) holder of Australian Financial Services Licence (AFSL 337 927).